The tetrapeptide tuftsin effectively impairs the binding of SARS-CoV-2 S1 to ACE2

In their recent study posted to the preprint server bioRxiv*, the researchers from China have shown that tuftsin, a natural phagocytosis-stimulating peptide, can effectively impair the binding of SARS-CoV-2 spike S1 subunit to ACE2 receptor in a dose-dependent manner and therefore can be considered a potential drug against SARS-CoV-2 infection.

Related Keywords

China , ,Image Credit ,Ace2 ,Coronavirus Disease Covid 19 ,Cars ,Ars Cov 2 ,Antibodies ,Binding Affinity ,Bioinformatics ,Chip ,Coronavirus ,Covid 19 ,Genes ,Olecule ,Pandemic ,Phagocytosis ,Eceptor ,Espiratory ,Evere Acute Respiratory ,Evere Acute Respiratory Syndrome ,Yndrome ,Virus ,